tirzepatide tablets skinnyrx Review 2026: Is It Legit? Pills, Cost & Affirm free tablet SkinnyRx: Injectable Tirzepatide (GLP-1)
Description
Orforglipron significantly reduced HbA1c to 2.1% in a phase II clinical trial assessing its use in T2DM, while dulaglutide achieved 1.1% and a placebo achieved 0.43% [106]
Tirzepatide trials (SURMOUNT-1) lasted 72 weeks
Mild injection site reactionsincluding redness, itching, or slight swellingare common and typically resolve within a few days
When these occur together, patients may interpret the constellation of symptoms as flu-like, even though they represent medication side effects rather than infectious illness
Geiselman, P
